China SXT Pharmaceuticals (SXTC) Finished Goods (2023 - 2025)

China SXT Pharmaceuticals' Finished Goods history runs 3 years deep, the most recent figure standing at $448668.0 for Q1 2025.

• In Q1 2025, Finished Goods fell 18.97% year-over-year to $448668.0; the TTM figure through Mar 2025 stood at $448668.0 (down 18.97% YoY), while the FY2025 annual figure was $448668.0, down 18.97% from the prior year.
• Finished Goods was $448668.0 for Q1 2025 at China SXT Pharmaceuticals, down from $553682.0 in the prior quarter.
• In the past five years, Finished Goods ranged from a high of $553682.0 in Q1 2024 to a low of $446866.0 in Q1 2023.
• Historically, Finished Goods has averaged $483072.0 across 3 years, with a median of $448668.0 in 2025.
• The sharpest annual moves came in 2024 and 2025: Finished Goods grew 23.9% in 2024, then declined 18.97% in 2025.
• A 3-year view of Finished Goods shows it stood at $446866.0 in 2023, then advanced by 23.9% to $553682.0 in 2024, then slipped by 18.97% to $448668.0 in 2025.
• The last three Finished Goods figures came in at $448668.0 (Q1 2025), $553682.0 (Q1 2024), and $446866.0 (Q1 2023), per Business Quant data.